Gluconeogenesis

Gluconeogenesis is the metabolic process by which the body synthesises glucose from non-carbohydrate precursors. This pathway is essential for maintaining blood glucose levels during periods of fasting, starvation, or intense exercise.

Substrate Precursors for Gluconeogenesis:

  • Lactate: Produced by skeletal muscle during anaerobic glycolysis or by red blood cells. It is transported to the liver and converted back into pyruvate by lactate dehydrogenase (the Cori Cycle).

  • Amino Acids: Primarily alanine; derived from the breakdown of muscle proteins during fasting. Glucogenic amino acids enter the pathway at the level of pyruvate or intermediates of the Tricarboxylic Acid (TCA) cycle.

  • Glycerol: Released during the hydrolysis of triacylglycerols (fats) in adipose tissue, glycerol can be phosphorylated and oxidised to enter the gluconeogenic pathway as dihydroxyacetone phosphate (DHAP).

Overcoming Glycolytic Barriers:

Gluconeogenesis is essentially the reversal of glycolysis; however, it is not a direct reversal because three reactions in glycolysis are highly exergonic and irreversible. It uses four specific enzymes to "bypass" these barriers.

  • Conversion of Pyruvate to Phosphoenolpyruvate (PEP):

    • This is a two-step process required to reverse the irreversible pyruvate kinase reaction of glycolysis.

      • Pyruvate Carboxylase: This mitochondrial enzyme converts pyruvate into oxaloacetate. This reaction requires ATP and the cofactor biotin.

      • PEP Carboxykinase (PEPCK): Oxaloacetate is then decarboxylated and phosphorylated by PEPCK to form Phosphoenolpyruvate (PEP), utilising GTP as the phosphate donor.

  • Conversion of Fructose 1,6-bisphosphate to Fructose 6-phosphate:

    • The irreversible phosphofructokinase-1 (PFK-1) step is bypassed by Fructose 1,6-bisphosphatase.

      • This enzyme performs a simple hydrolytic cleavage of the phosphate group at the C-1 position, which is a major regulatory point in the pathway.

  • Conversion of Glucose 6-phosphate to Glucose:

    • The final bypass reverses the hexokinase reaction. The enzyme Glucose 6-phosphatase hydrolyses glucose 6-phosphate to produce free glucose, which can then be released into the bloodstream.

Tissue and Cellular Localisation:

The distribution of gluconeogenic activity is highly tissue-specific, ensuring that the body can support blood glucose levels systemically.

  • Primary Organs: Gluconeogenesis occurs predominantly in the liver, with a significant contribution from the kidneys and the small intestine during prolonged fasting.

  • Subcellular Location: Most of the reactions of gluconeogenesis occur within the cytosol. However, the initial step (pyruvate to oxaloacetate) takes place in the mitochondria, and the final step (glucose 6-phosphate to glucose) occurs in the lumen of the endoplasmic reticulum.

The Pentose Phosphate Pathway (PPP):

The Pentose Phosphate Pathway (also known as the phosphogluconate pathway) runs parallel to glycolysis and serves two primary biosynthetic purposes rather than energy production.

  • NADPH Production: The pathway generates NADPH, which is essential as a reducing agent in fatty acid synthesis, steroid synthesis, and the maintenance of reduced glutathione for protection against oxidative stress.

  • Ribose 5-phosphate Synthesis: It provides the five-carbon sugars necessary for the biosynthesis of nucleotides (DNA and RNA).

Reaction Phases: The pathway consists of an irreversible oxidative phase (generating NADPH) and a reversible non-oxidative phase (interconverting sugars for glycolysis or nucleotide synthesis).

Metabolic Regulation and Clinical Relevance:

The balance between glycolysis and gluconeogenesis is tightly regulated to prevent futile cycles and to respond to the body's energy needs.

Hormonal and Physiological Control:

  • Insulin vs. Glucagon: Insulin generally inhibits gluconeogenesis by promoting glucose uptake and storage, whereas glucagon stimulates it by upregulating key enzymes like PEPCK and Fructose 1,6-bisphosphatase.

  • Insulin Insensitivity: Pathological states such as trauma or diabetes can lead to insulin resistance. In these conditions, the glucose receptors (GLUTs) may become less responsive, leading to impaired glucose homeostasis and elevated blood sugar levels even when internal synthesis is active.

  • Allosteric Modulators:

    • Acetyl CoA: High levels of Acetyl CoA (indicating high fat oxidation) activate pyruvate carboxylase.

    • Fructose 2,6-bisphosphate: A potent inhibitor of gluconeogenesis; high levels (stimulated by insulin) inhibit Fructose 1,6-bisphosphatase, effectively turning off glucose synthesis.